Market News
Global Bio-imaging Market- Recent Developments
Product and Technology Launch
- On October 2, 2023, Exo, a medical imaging startup, launched its newest medical imaging device, Exo Iris, which is a portable ultrasound device that combines point-of-care imaging, artificial intelligence, and health information technology (IT) systems.
- On May 5, 2023, Revvity, Inc., a biotechnology company, enhanced imaging portfolio designed to drive innovation across diverse applications in preclinical research with the launch of three systems. These new innovations include the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, further elevating versatility and sensitivity standards in in vivo optical imaging. QuantumTM GX3 microCT structural imaging solution was also launched with increased resolution and speed for both in vivo and ex vivo imaging, designed to facilitate researchers studying disease biology or evaluating and fast-tracking therapeutic candidates. And making its global debut is the Vega ultrasound system.
Business Development Activities by the Market Players
- On January 5, 2024, Biocare Medical, a leader in fully open automated instrumentation, announced collaboration with Molecular Instruments (MI), the inventor of the hybridization chain reaction (HCR) imaging technology. This partnership brings together Biocare Medical's expertise in automated bio imaging systems with MI's suite of advanced HCR Products, by setting a new standard in automated in situ hybridization (ISH) and immunohistochemistry (IHC).
- On January 5, 2023, Bruker Corporation, a global manufacturer of high-end analytical instruments, announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker Corporation’s advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products, which generate high information content.
- In January 2021, Olympus Corporation, manufacturer of optics and reprography products, entered into an agreement to acquire Quest Photonic Devices B.V. for up to US$60.7 million (€50 million) including milestone payments to strengthen its surgical endoscopy capabilities. This will incorporate Quest Photonic Devices B.V's advanced Fidelity National Information Services (FIS) capabilities into Olympus Corporation’s comprehensive medical imaging portfolio.
U.S.: 
U.K. : 
India : 
